KLOW Blend
also known as Klow, KLOW, GHK-Cu + BPC-157 + TB-500 + KPV blend
A four-component blend that co-formulates GHK-Cu, BPC-157, TB-500, and KPV in a single vial. It extends the three-component Glow blend by adding KPV, the C-terminal tripeptide of alpha-MSH. There is no published study of the combination itself; the rationale rests entirely on each component's own literature, documented on its plate. A third-party content assay quantifies each component present in the vial — see the Lab verification section. Listed because blends dominate the practical market yet have no reference coverage.
At a glance
SQ · Reconstituted
Primary target — Several — copper-peptide signalling (GHK-Cu), the actin-regulating and angiogenic pathways of BPC-157 and TB-500, and the melanocortin-derived tripeptide KPV.
Pathway — The blend is a co-formulation, not a single mechanism. Each component acts on its own pathway; follow the component plates for the mechanism and evidence of each..
Downstream effect — Any effect is extrapolated from the individual components; the combination has not been studied as a unit.
| Parameter | Value |
|---|---|
| Fixed proportion | The four components share one vial in a fixed ratio, so a single draw contains all four. There is no combination protocol — refer to each component's plate. |
| Reconstitution | One vial, one diluent volume. The calculator's blend mode converts a chosen draw volume into each component's amount. |
| Evidence basis | No combination-specific data; rests on the component literature |
| Form | Lyophilized multi-component vial |
Components
A blend is a co-formulation. Each component has its own mechanism and evidence — follow its plate.
Work out the per-component draw-volume math in the calculator’s blend mode.
Lab verification
Third-party lab reports tied to batch codes, re-verifiable at the issuing lab. A fact and where to re-check it — never a verdict.
- — Active malignancy (per the component contraindications)
- — Pregnancy / breastfeeding
- — Any contraindication of GHK-Cu, BPC-157, TB-500, or KPV individually
- 01Form
Lyophilized blend — reconstitute with bacteriostatic water.
- 02Reconstitution
One vial, one diluent volume. The calculator's blend mode shows each component's delivered amount per draw.
- 03Route
Subcutaneous injection.
- 04Storage
Reconstituted: refrigerate 2–8 °C. Lyophilized: cool, dry, out of light.
Sources
of 27 rendered claims carry a resolvable citation.